Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2017 (2017), Article ID 6081724, 10 pages
https://doi.org/10.1155/2017/6081724
Research Article

Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging

1Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Hubei Key Laboratory of Molecular Imaging, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Correspondence should be addressed to Chunxia Qin and Xiaoli Lan

Received 6 September 2017; Accepted 4 December 2017; Published 24 December 2017

Academic Editor: Yuebing Wang

Copyright © 2017 Yingying Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. C. Dreaden, A. M. Alkilany, X. Huang, C. J. Murphy, and M. A. El-Sayed, “The golden age: gold nanoparticles for biomedicine,” Chemical Society Reviews, vol. 41, no. 7, pp. 2740–2779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Same, A. Aghanejad, S. A. Nakhjavani, J. Barar, and Y. Omidi, “Radiolabeled theranostics: Magnetic and gold nanoparticles,” BioImpacts, vol. 6, no. 3, pp. 169–181, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Morales-Avila, G. Ferro-Flores, B. E. Ocampo-García et al., “Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression,” Bioconjugate Chemistry, vol. 22, no. 5, pp. 913–922, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Xiao, H. Hong, V. Z. Matson et al., “Gold nanorods conjugated with doxorubicin and cRGD for combined anti-cancer drug delivery and PET imaging,” Theranostics, vol. 2, no. 8, pp. 757–768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Au, D. Zheng, F. Zhou, Z.-Y. Li, X. Li, and Y. Xia, “A quantitative study on the photothermal effect of immuno gold nanocages targeted to breast cancer cells,” ACS Nano, vol. 2, no. 8, pp. 1645–1652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tian, W. Lu, R. Zhang et al., “Tumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model,” Molecular Imaging and Biology, vol. 15, no. 5, pp. 614–624, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Xie, Z. J. Wang, A. Bao, B. Goins, and W. T. Phillips, “In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts,” International Journal of Pharmaceutics, vol. 395, no. 1-2, pp. 324–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Shao, A. Agarwal, J. R. Rajian, N. A. Kotov, and X. Wang, “Synthesis and bioevaluation of 125I-labeled gold nanorods,” Nanotechnology, vol. 22, no. 13, Article ID 135102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-H. Chou, C.-D. Chen, and C. R. C. Wang, “Highly efficient, wavelength-tunable, gold nanoparticle based optothermal nanoconvertors,” The Journal of Physical Chemistry B, vol. 109, no. 22, pp. 11135–11138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Wang, C. Bao, S. Liang et al., “RGD-conjugated silica-coated gold nanorods on the surface of carbon nanotubes for targeted photoacoustic imaging of gastric cancer,” Nanoscale Research Letters, vol. 9, no. 1, article 264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Heidari, M. Salouti, and R. Sariri, “Breast cancer photothermal therapy based on gold nanorods targeted by covalently-coupled bombesin peptide,” Nanotechnology, vol. 26, no. 19, Article ID 195101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Su, Y. Dang, G. Liang, and G. Liu, “Iodine-125-labeled cRGD-gold nanoparticles as tumor-targeted radiosensitizer and imaging agent,” Nanoscale Research Letters, vol. 10, article 160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Zhong, L. Wen, S. Yang, L. Xiang, Q. Chen, and D. Xing, “Imaging-guided high-efficient photoacoustic tumor therapy with targeting gold nanorods,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 11, no. 6, pp. 1499–1509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. P. P. Joshi, S. J. Yoon, W. G. Hardin, S. Emelianov, and K. V. Sokolov, “Conjugation of antibodies to gold nanorods through Fc portion: synthesis and molecular specific imaging,” Bioconjugate Chemistry, vol. 24, no. 6, pp. 878–888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Vigderman, B. P. Khanal, and E. R. Zubarev, “Functional gold nanorods: synthesis, self-assembly, and sensing applications,” Advanced Materials, vol. 24, no. 36, pp. 4811–4841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Haubner, F. Bruchertseifer, M. Bock, H. Kessler, M. Schwaiger, and H.-J. Wester, “Synthesis and biological evaluation of a 99mTc-labelled cyclic RGD peptide for imaging the αvβ3 expression,” Nuklearmedizin, vol. 43, no. 1, pp. 26–32, 2004. View at Google Scholar · View at Scopus
  17. J. Wan, J.-H. Wang, T. Liu, Z. Xie, X.-F. Yu, and W. Li, “Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo,” Scientific Reports, vol. 5, Article ID 11398, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Singh, R. Pasricha, U. M. Bhatta, P. V. Satyam, M. Sastry, and B. L. V. Prasad, “Effect of halogen addition to monolayer protected gold nanoparticles,” Journal of Materials Chemistry, vol. 17, no. 16, pp. 1614–1619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. V. Gudkov, N. Y. Shilyagina, V. A. Vodeneev, and A. V. Zvyagin, “Targeted radionuclide therapy of human tumors,” International Journal of Molecular Sciences, vol. 17, no. 1, article 33, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Dechantsreiter, E. Planker, B. Mathä et al., “N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists,” Journal of Medicinal Chemistry, vol. 42, no. 16, pp. 3033–3040, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, “Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review,” Journal of Controlled Release, vol. 65, no. 1-2, pp. 271–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Torchilin, “Tumor delivery of macromolecular drugs based on the EPR effect,” Advanced Drug Delivery Reviews, vol. 63, no. 3, pp. 131–135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Fang, H. Nakamura, and H. Maeda, “The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect,” Advanced Drug Delivery Reviews, vol. 63, no. 3, pp. 136–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Qin, X. Lan, J. He et al., “An in vitro and in vivo evaluation of a reporter gene/probe system hERL/18F-FES,” PLoS ONE, vol. 8, no. 4, Article ID e61911, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Weissleder, “A clearer vision for in vivo imaging,” Nature Biotechnology, vol. 19, no. 4, pp. 316-317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Sun, X. Huang, X. Yan et al., “Chelator-free 64Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy,” ACS Nano, vol. 8, no. 8, pp. 8438–8446, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Tsoukalas, G. Laurent, G. Jiménez Sánchez et al., “Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging,” EJNMMI Physics, vol. 2, no. 1, article A89, 2015. View at Publisher · View at Google Scholar
  28. L. Karmani, V. Bouchat, C. Bouzin et al., “89Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy,” Nanomedicine, vol. 9, no. 13, pp. 1923–1937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-H. Kim, J. Jeon, S. H. Hong et al., “Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125,” Small, vol. 7, no. 14, pp. 2052–2060, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H.-W. Kao, Y.-Y. Lin, C.-C. Chen et al., “Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 11, pp. 3180–3185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. D. K. Smith, N. R. Miller, and B. A. Korgel, “Iodide in CTAB prevents gold nanorod formation,” Langmuir, vol. 25, no. 16, pp. 9518–9524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Cheng, S. Dong, and E. Wang, “Iodine-induced gold-nanoparticle fusion/fragmentation/aggregation and iodine-linked nanostructured assemblies on a glass substrate,” Angewandte Chemie International Edition, vol. 42, no. 4, pp. 449–452, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Hong, Y. Zhang, J. Sun, and W. Cai, “Molecular imaging and therapy of cancer with radiolabeled nanoparticles,” Nano Today, vol. 4, no. 5, pp. 399–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. B. D. Chithrani, A. A. Ghazani, and W. C. W. Chan, “Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells,” Nano Letters, vol. 6, no. 4, pp. 662–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Harush-Frenkel, E. Rozentur, S. Benita, and Y. Altschuler, “Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells,” Biomacromolecules, vol. 9, no. 2, pp. 435–443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Luna-Gutiérrez, G. Ferro-Flores, B. Ocampo-García et al., “177Lu-labeled monomeric, dimeric and multimeric RGD peptides for the therapy of tumors expressing α(ν)β(3) integrins,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 55, no. 4, pp. 140–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Vilchis-Juárez, G. Ferro-Flores, C. Santos-Cuevas et al., “Molecular targeting radiotherapy with Cyclo-RGDfK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice,” Journal of Biomedical Nanotechnology, vol. 10, no. 3, pp. 393–404, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Huang, X. Peng, Y. Wang et al., “A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands,” ACS Nano, vol. 4, no. 10, pp. 5887–5896, 2010. View at Publisher · View at Google Scholar · View at Scopus